Deepak Chem Tech Limited (DCTL) issued ₹135 Crore worth of 9% OCRPS to subsidiaries DPL (₹110 Cr) and DNL (₹25 Cr) on March 26, 2026.
The fund infusion aims to strengthen DCTL's capital base and support project expenses and general corporate purposes in Gujarat.
DCTL's pre-allotment paid-up capital stood at ₹2,099.50 Crore; DNL retains 100% equity control of DCTL post-allotment.
Transactions are classified as related party transactions conducted at arms-length and at par (₹100 face value per share).